Works about RITUXIMAB
Results: 5000
Single (375 mg/m<sup>2</sup>) vs. double dose of rituximab along with mycophenolate mofetil for children with steroid-dependent/frequently relapsing nephrotic syndrome: a multicentre open-label randomized controlled trial.
- Published in:
- Pediatric Nephrology, 2025, v. 40, n. 4, p. 995, doi. 10.1007/s00467-024-06619-8
- By:
- Publication type:
- Article
Unusual presentations of myasthenia gravis and misdiagnosis.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-91470-6
- By:
- Publication type:
- Article
Borrelia spielmanii--Associated Neuroborreliosis in Patient Receiving Rituximab, Belgium.
- Published in:
- Emerging Infectious Diseases, 2025, v. 31, n. 2, p. 341, doi. 10.3201/eid3102.240777
- By:
- Publication type:
- Article
Using a Natural Triterpenoid to Unlock the Antitumor Effects of Autophagy in B-Cell Lymphoma.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 445, doi. 10.3390/biomedicines13020445
- By:
- Publication type:
- Article
The association between radiotherapy and the prognosis of follicular lymphoma patients with different characteristics in the rituximab era: a cohort study based on Surveillance, Epidemiology and End Results.
- Published in:
- Annals of Hematology, 2025, v. 104, n. 1, p. 691, doi. 10.1007/s00277-025-06209-0
- By:
- Publication type:
- Article
Outcome of patients with diffuse large B-cell lymphoma and testicular involvement – real world data.
- Published in:
- Annals of Hematology, 2025, v. 104, n. 1, p. 675, doi. 10.1007/s00277-024-06025-y
- By:
- Publication type:
- Article
Interstitial lung disease presents with varying characteristics in patients with non-Hodgkin lymphoma undergoing rituximab-containing therapies.
- Published in:
- Annals of Hematology, 2025, v. 104, n. 1, p. 527, doi. 10.1007/s00277-024-06013-2
- By:
- Publication type:
- Article
Mortality Rates Among Individuals Diagnosed with Pemphigus: 12-Year Experience in Tehran, Iran.
- Published in:
- Archives of Iranian Medicine (AIM), 2025, v. 28, n. 2, p. 95, doi. 10.34172/aim.31996
- By:
- Publication type:
- Article
Antibody Therapy for Patients with Lymphoid Malignancies: Past and Present.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1711, doi. 10.3390/ijms26041711
- By:
- Publication type:
- Article
Navigating Epstein–Barr Virus (EBV) and Post-Transplant Lymphoproliferative Disorder (PTLD) in Pediatric Liver Transplantation: Current Knowledge and Strategies for Treatment and Surveillance.
- Published in:
- Viruses (1999-4915), 2025, v. 17, n. 2, p. 254, doi. 10.3390/v17020254
- By:
- Publication type:
- Article
Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases.
- Published in:
- 2013
- By:
- Publication type:
- Report
Long lasting remission by rituximab in a patient with primary cold agglutinin autoimmune haemolytic anaemia.
- Published in:
- 2011
- By:
- Publication type:
- Report
Efficiently Reducing Medical Costs through Drug Vial Optimization and Multidose Vials for the Utilization of Cancer Drug Compounding Robots: Efficiently Reducing Medical Costs through Cancer Drug Compounding Robots: E. Usami et al.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 2, p. 75, doi. 10.1007/s40267-025-01140-w
- By:
- Publication type:
- Article
Management of lupus nephritis in children needs special considerations, but more paediatric data are required: Management of lupus nephritis in children needsspecial considerations: A. McGuigan.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 12, p. 470, doi. 10.1007/s40267-024-01120-6
- By:
- Publication type:
- Article
Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 9
- By:
- Publication type:
- Article
Long-term follow-up in lupus nephritis patients treated with rituximab - clinical and histopathological response.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the Autoimmune and Rituximab registry.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Rituximab dissociates the tight link between disease activity and joint damage in rheumatoid arthritis patients.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
A pilot open label Phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome.
- Published in:
- Current Medical Literature: Rheumatology, 2013, v. 32, n. 1, p. 31
- By:
- Publication type:
- Article
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.
- Published in:
- Current Medical Literature: Rheumatology, 2013, v. 32, n. 1, p. 28
- By:
- Publication type:
- Article
Two-year results of an open pilot study of a 2-treatment course with rituximab in patients with early systemic sclerosis with diffuse skin involvement.
- Published in:
- Current Medical Literature: Rheumatology, 2013, v. 32, n. 1, p. 19
- By:
- Publication type:
- Article
Rituximab versus oral cyclophosphamide for treatment of relapses of proliferative lupus nephritis: a clinical observational study.
- Published in:
- Current Medical Literature: Rheumatology, 2013, v. 32, n. 1, p. 22
- By:
- Publication type:
- Article
Systemic Lupus Erythematosus.
- Published in:
- Current Medical Literature: Rheumatology, 2012, v. 31, n. 4, p. 117
- Publication type:
- Article
Systemic Lupus Erythenatosus.
- Published in:
- Current Medical Literature: Rheumatology, 2012, v. 31, n. 3, p. 93
- Publication type:
- Article
Sjögren's Syndrome.
- Published in:
- Current Medical Literature: Rheumatology, 2012, v. 31, n. 2, p. 48
- Publication type:
- Article
Pediatric Rheumatology.
- Published in:
- Current Medical Literature: Rheumatology, 2012, v. 31, n. 1, p. 31
- Publication type:
- Article
Feline high‐grade and large granular lymphocyte alimentary lymphomas treated with COP‐ or CHOP‐based chemotherapy: A multi‐centric retrospective study of 57 cases.
- Published in:
- Veterinary & Comparative Oncology, 2024, v. 22, n. 2, p. 186, doi. 10.1111/vco.12965
- By:
- Publication type:
- Article
Large granular lymphocyte lymphoma in 65 dogs (2005–2023).
- Published in:
- Veterinary & Comparative Oncology, 2024, v. 22, n. 1, p. 115, doi. 10.1111/vco.12959
- By:
- Publication type:
- Article
Effect of proteasome inhibitors on canine lymphoma cell response to CHOP chemotherapy in vitro.
- Published in:
- Veterinary & Comparative Oncology, 2024, v. 22, n. 1, p. 96, doi. 10.1111/vco.12957
- By:
- Publication type:
- Article
Calculation of dose intensity and comparison of published methods using a cohort of canine T‐cell lymphoma patients undergoing CHOP‐based chemotherapy.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 339, doi. 10.1111/vco.12894
- By:
- Publication type:
- Article
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy‐treated diffuse large B‐cell lymphoma.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 200, doi. 10.1111/vco.12876
- By:
- Publication type:
- Article
Prognostic significance of CD25 expression in dogs with a noninvasive diagnosis of B‐cell lymphoma treated with CHOP chemotherapy.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 1, p. 28, doi. 10.1111/vco.12857
- By:
- Publication type:
- Article
Clinicopathological characteristics and prognostic factors for canine multicentric non‐indolent T‐cell lymphoma: 107 cases.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 4, p. 656, doi. 10.1111/vco.12589
- By:
- Publication type:
- Article
Epidemiological, pathological and immunohistochemical aspects of 125 cases of feline lymphoma in Southern Brazil.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 2, p. 224, doi. 10.1111/vco.12535
- By:
- Publication type:
- Article
Women with Diffuse Large B Cell Lymphoma Benefit More from Rituximab-Containing Chemotherapy.
- Published in:
- Journal of Women's Health (15409996), 2019, v. 28, n. 2, p. 203, doi. 10.1089/jwh.2018.6949
- By:
- Publication type:
- Article
Glycoengineering of NK Cells with Glycan Ligands of CD22 and Selectins for B‐Cell Lymphoma Therapy.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 7, p. 3647, doi. 10.1002/ange.202005934
- By:
- Publication type:
- Article
Peptide‐Directed DNA‐Templated Protein Labelling for The Assembly of a Pseudo‐IgM.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 27, p. 9166, doi. 10.1002/ange.201903134
- By:
- Publication type:
- Article
Phase 2 multicentre study of single‐agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance).
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 15, p. 53, doi. 10.1111/bjh.15768
- By:
- Publication type:
- Article
Clinical characteristics of patients with early relapse during B-cell depletion after rituximab treatment for complicated steroid-dependent nephrotic syndrome.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Podocyte sphingomyelin phosphodiesterase acid-like 3b decreases among children with idiopathic nephrotic syndrome.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 1, p. 44, doi. 10.1007/s10157-020-01970-0
- By:
- Publication type:
- Article
Efficacy of repeat-dose rituximab maintenance therapy for minimal change disease in adults.
- Published in:
- Clinical & Experimental Nephrology, 2020, v. 24, n. 12, p. 1132, doi. 10.1007/s10157-020-01943-3
- By:
- Publication type:
- Article
Should rituximab be administered before cyclophosphamide as a first-line steroid-sparing agent to young children with steroid-dependent nephrotic syndrome?
- Published in:
- 2020
- By:
- Publication type:
- Letter
Therapeutic efficacy of rituximab for the management of adult-onset steroid-dependent nephrotic syndrome: a retrospective study.
- Published in:
- Clinical & Experimental Nephrology, 2019, v. 23, n. 2, p. 207, doi. 10.1007/s10157-018-1630-y
- By:
- Publication type:
- Article
Rituximab in primary membranous nephropathy: beyond a B-cell-centered paradigm?
- Published in:
- Clinical & Experimental Nephrology, 2018, v. 22, n. 1, p. 208, doi. 10.1007/s10157-017-1437-2
- By:
- Publication type:
- Article
Relapse of nephrotic syndrome during post-rituximab peripheral blood B-lymphocyte depletion.
- Published in:
- Clinical & Experimental Nephrology, 2018, v. 22, n. 1, p. 110, doi. 10.1007/s10157-017-1415-8
- By:
- Publication type:
- Article
Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation.
- Published in:
- Clinical & Experimental Nephrology, 2017, v. 21, n. 4, p. 705, doi. 10.1007/s10157-016-1321-5
- By:
- Publication type:
- Article
Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
- Published in:
- Clinical & Experimental Nephrology, 2017, v. 21, n. 4, p. 671, doi. 10.1007/s10157-016-1328-y
- By:
- Publication type:
- Article
Rituximab for nephrotic syndrome in children.
- Published in:
- Clinical & Experimental Nephrology, 2017, v. 21, n. 2, p. 193, doi. 10.1007/s10157-016-1313-5
- By:
- Publication type:
- Article
Amelioration of the adverse effects of prednisolone by rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome.
- Published in:
- Clinical & Experimental Nephrology, 2016, v. 20, n. 1, p. 103, doi. 10.1007/s10157-015-1139-6
- By:
- Publication type:
- Article